Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 74 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Accommodation Clear all

Conditions: Asthenopia, Contact Lenses, Ocular Accommodation, Convergence, Excess
Interventions: Test Daily Disposable Soft Contact Lenses, Control Daily Disposable Soft Contact Lenses; Device
Lead sponsor: State University of New York College of Optometry; Other
Eligibility: 18 Years to 35 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Gastroparesis
Interventions: sapropterin dihydrochloride; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: ADHD
Interventions: Methylphenidate Hydrochloride ER, Behavioral classroom, Placebo, General Classroom, Academic Accommodations; Drug · Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Miami, Florida • Amherst, New York

Conditions: Coronary Artery Disease, Delirium
Interventions: Ropivacaine, Ketamine, Remifentanil, Dexmedetomidine, Rocuronium, Propofol, Sevoflurane, EEG monitoring; Drug · Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gastroesophageal Reflux Disease
Interventions: Not listed
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 1 Year to 30 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pain, Acute
Interventions: Interoceptive breathing awareness through use of audio and visual virtual technology aid, Interoceptive breathing awareness without use of audio or visual virtual reality; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Accommodative Insufficiency, Ill-sustained Accommodation
Interventions: Not listed
Lead sponsor: Western University of Health Sciences; Other
Eligibility: 18 Years to 30 Years
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Pomona, California

Conditions: Heart Failure
Interventions: Edoxaban; Drug
Lead sponsor: LifeBridge Health; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Will Consuming Eggs With a Mixed Vegetable Salad Increase Carotenoid Absorption
Interventions: Egg consumption; Other
Lead sponsor: Purdue University; Other
Eligibility: 19 Years to 45 Years · Male only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Computer Vision Syndrome, Accommodation
Interventions: Stenfilcon A contact lens designs with and without Digital Boost technology that incorporate a 0.3D add power into the lens; Device
Lead sponsor: Southern College of Optometry; Other
Eligibility: 18 Years to 35 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Cardiovascular Diseases, Metabolic Syndrome, Obesity, Prediabetes, Mental Health Disorders, Endocrine Dysfunction, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease (CKD)
Interventions: Blood Work; Other
Lead sponsor: Clindove Research LLC; Other
Eligibility: 18 Years and older
Enrollment: 7,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Behavior, Process, Acceptance, Inertia of Accommodation
Interventions: targetted implementation strategies; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
Interventions: Metformin, semaglutide, Anti-hypertensives, Lipid Lowering Medication, Life style intervention, Fezolinetant, Hormonal therapy; Drug · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 45 Years to 55 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Aurora, Colorado • Chapel Hill, North Carolina • Richmond, Virginia

Conditions: Acute Coronary Syndromes
Interventions: CER-001, Placebo; Drug
Lead sponsor: Cerenis Therapeutics, SA; Industry
Eligibility: 18 Years and older
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 13
States / cities: Huntsville, Alabama • San Diego, California • Torrance, California + 9 more

Conditions: Difficulty Focusing, Poor Concentration, Poor Memory, Low Energy
Interventions: Auri Super Mushroom Daily Gummies For Kids; Dietary Supplement
Lead sponsor: Auri Nutrition; Industry
Eligibility: 4 Years to 12 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Communication Disabilities
Interventions: Implementation Support Package; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 126,870 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 5
States / cities: Aurora, Colorado • Denver, Colorado • Chicago, Illinois + 2 more

Conditions: Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer, Colorectal Cancer
Interventions: ADI-PEG 20 plus modified FOLFOX6; Drug
Lead sponsor: Polaris Group; Industry
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 10
States / cities: San Francisco, California • Atlanta, Georgia • Chicago, Illinois + 7 more

Conditions: Hyperopia
Interventions: Glasses; Device
Lead sponsor: Donald O Mutti, OD, PhD; Other
Eligibility: 8 Weeks to 15 Weeks
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Amblyopia Bilateral, Hyperopia of Both Eyes, Astigmatism Bilateral, Accommodation Disorder
Interventions: objective pediatric vision screen "GCK glow fixation"; Diagnostic Test
Lead sponsor: Alaska Blind Child Discovery; Other
Eligibility: 1 Month to 20 Years
Enrollment: 133 participants
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Anchorage, Alaska

Conditions: Anxiety Disorders
Interventions: Project EMPOWER, Online Resources and Referrals; Behavioral · Other
Lead sponsor: Stony Brook University; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Distance Viewing, Prolonged Near Viewing
Interventions: Near viewing first, Distant viewing first; Other
Lead sponsor: Rochester Institute of Technology; Other
Eligibility: 18 Years to 35 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Myopia
Interventions: Atropine; Drug
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years to 35 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Study Focusing on Integrated Versus Non-integrated Psychiatric Care in, Opioid-dependent and Methadone Treated Patients With Other Psychiatric, Diagnoses
Interventions: Counseling compliance; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Myopia, Accommodation
Interventions: Multifocal soft contact lenses; Device
Lead sponsor: State University of New York College of Optometry; Other
Eligibility: 8 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Connecting Contact Lenses and Digital Technology

Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis.

Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom

The PATHFINDER Study: A Feasibility Trial

Gastric Accommodation and Gastroesophageal Reflux

Visual and Auditory Neuromodulation of Pain Perception

Accommodation Disorders

Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

Effects of Egg Consumption on Carotenoid Absorption From Co-consumed, Non-Egg Food

Comparison of Two Contact Lens Designs

Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

Implementation of Ultrasound Guided Central Venous Catheter Confirmation Protocol

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

CER-001 Atherosclerosis Regression ACS Trial

A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

Implementation of Communication Disability Collection and Accommodations in Primary Care Settings

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Enhancement of Emmetropization in Highly Hyperopic Infants

Hyperopia Detection GCK With Glow Fixation

Empowering Anxious Parents to Manage Child Avoidance Behaviors

Measuring How Quickly the Eye Focuses After Sustained Viewing of Close-up Images and Videos

The Effects of Low Concentration Atropine on Pupil Size and Accommodation

Improving Delivery of Mental Health Services for Patients With Drug Use and Other Behavioral and Emotional Problems

Dynamic Change in Accommodation After Wearing Multifocal Soft Contact Lenses for Myopia Control